Quanterix is proud to sponsor the Alzheimer’s and Parkinson’s Drug Development Summit, taking place March 18-20 in Boston, MA. This event brings together industry experts to share groundbreaking research and advancements in Alzheimer’s and Parkinson’s drug development. Attendees will engage in insightful discussions and presentations on biomarkers, clinical development, and innovative approaches to address neurodegenerative diseases.

Visit the Quanterix team in the Partner Exhibit area or connect with us during the poster presentation hours to learn more about our recent study on BD-Tau.

We look forward to connecting with you in Boston about Quanterix’s cutting-edge innovations in biomarker research!